Always a debate as to whether CPT or the Vest is better.
First off I will say I firmly believe that European/Canadian/Australian governments don't discuss or offer the Vest because they have socialized medicine and don't wish to pay for it. It's sad and I think it partly contributes to lower median survival rates verus the US.
Secondly, one thing that makes the Vest adventageous is that it is done the same way, consistently, every time. When you have a human performing manual CPT, there is always variation - no two sessions are the same.
Finally, you're never dependent on someone else. I bet everyone who does manual CPT has missed a sessiond to do another person not having time/wanting to/whatever reason being able to do the session for the CFer. You never have that with the Vest (unless you're in Europe with your American Vest and you didn't bring your transformer).
You have one life. One set a lungs. If there's a possibility to slighly imrove your lung function and possibly add years of quality and/or quantity of life, the choice is a no-brainer to me.
Here are a few studies measuring mucus clearance of CPT versus the Vest:
In a crossover study comparing the volume of mucus cleared using HFCC vs. CPT,
HFCC therapy was shown to be more effective than standard CPT for all outcomes
Title: Hansen LG, Warwick WJ. High-frequency chest compression system to aid in
clearance of mucus from the lungs. Biomed Instrum Technol 1990;
Method: 5 CF patients received 30 HFCC and 30 professionally administered CPT
• Sessions matched for time of day
• Session durations uniform (unspecified)
• Total volume of expectorated sputum collected
• Mean volume with each modality compared
• PFTs compared
Results: Compared to 30 CPT treatments, 30 HFCC treatments showed:
• Significantly more mucus clearance with HFCC (3.3cc/HFCC session
vs. 1.8 cc/ CPT session [p<0.001])
• Improved lung function
• Improved ventilation
• No adverse events
HFCC was shown to be more effective than CPT for every outcome measure
This large randomized controlled crossover trial compared high frequency chest
compression (HFCC) with professionally administered chest physiotherapy (CPT) in 29
cystic fibrosis (CF) patients hospitalized with acute pulmonary exacerbations. Sputum
weight (wet and dry) was a proxy for efficacy. Results showed nearly three times greater
sputum clearance in the HFCC group.
Title: Kluft J, Beker L, Castagnino M, Gaiser J, Chaney H, Fink R. A comparison of bronchial
drainage treatments in cystic fibrosis. Pediatr Pulmonol 1996; 22: 271-274.
Design: A prospective, randomized controlled, cross-over
Method: Twenty-nine hospitalized CF patients with acute pulmonary exacerbations received
randomized treatment with HFCC and CPT
• Two days with each therapy over a 4-day period
• Three 30 minute therapy sessions/day
• Expectorated secretions collected during each 30 minute therapy session
• Twelve specimens per patient
• Wet and dry weights determined gravimetrically
• Means and standard deviations ( X + SD) based on 348 total sputum samples
Weight CPT/PD (X + SD) HFCC (X+ SD) P VALUE
Wet weight (g) 2.86 + 4.0 6.76 + 9.7 0.001
Dry weight (g) 0.26 + 0.45 0.74 + 2.4 0.01
• HFCC is effective: Dry sputum weights were nearly threefold greater than those
expectorated with professionally administered CPT
• No adverse effects were observed
• Patient tolerance and acceptance were high
In a long-term study comparing chest physiotherapy (CPT) to high frequency chest
compression (HFCC) in cystic fibrosis (CF) patients, 94% showed positive improvements for percent predicted forced vital capacity (FVC) and forced expiratory volume in one minute (FEV1) after two years of HFCC therapy. Most showed clinical improvement. The long - term FVC and FEV1 gains shown in this study are unprecedented.
Title: Warwick WJ, Hansen LG. The long-term effect of high-frequency chest
compression therapy on pulmonary complications of cystic fibrosis.
Pediatr Pulmonol 1991; 11:265-271.
Method: FEV1 scores recorded during 2 years of CPT were compared with scores
during 2 years of subsequent HFCC in sixteen CF patients with mild to severe
• CPT 1 - 4X daily for a mean of 23.2 months (range: 14-27
• 1 - 4X daily HFCC for a mean of 21.6 months (range:7-26 months)
• 30-minutes daily minimum for 5 minutes at each of 6 frequencies
• Individual patient therapy times ranged from 30-240 minutes daily
• Concomitant coughing and huffing techniques used
Results: Two-sided t-test analysis:
• Slopes more positive for FVC and FEV1 during HFCC therapy compared
with manual CPT
• Significance level for both FVC and FEV1: P < 0.001
This short-term evaluation of the effect of HFCC on pulmonary function compared with
chest physiotherapy (CPT) or alternative therapies in 54 CF patients showed significant
improvements in FEV1 after an average 3 months of HFCC treatment.
Title: Anbar RD, Powell KN, Iannuzzi DM. Short-term effects of ThAIRapy® Vest on
pulmonary functions of cystic fibrosis patients. Am J Respir and Crit Care Med
1998; 157 (Suppl 3): A130.
Design: Retrospective Chart Review
Method: Pulmonary function data gathered by retrospective chart review was analyzed for
54 CF patients meeting inclusion criteria:
• Age > 5 years (average = 17 years)
• Compliant HFCC therapy for at least 6 months
• Average HFCC use = 19 minutes/day (+13 minutes)
Prior use of CPT or not
○ 61% used chest physiotherapy (CPT)
○ 39% had NOT used CPT
Post - HFCC PFT’s were compared with best PFT scores obtained 0-6 months
Results: Best PFT results:
12 – 18 mo pre - HFCC FEV1 (+SD) 78+26 FVC (+SD) 95+24
0 – 6 mo pre - HFCC FEV1 (+SD) 76+26 FVC (+SD) 97+24
0 – 6 mo post - HFCC FEV1 (+SD) 82+29 FVC (+SD) 101+26
• FEV1 values improved an average of 8% overall
• FEV1 values improved an average of 7 % in patients using CPT prior to
• FEV1 values improved an average of 11% in patients using non-CPT
therapies prior to HFCC
• No adverse events were reported